Robert S. Yamamoto

953 total citations
46 papers, 756 citations indexed

About

Robert S. Yamamoto is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Robert S. Yamamoto has authored 46 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 12 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Robert S. Yamamoto's work include Immune Cell Function and Interaction (12 papers), Immune Response and Inflammation (10 papers) and Immunotherapy and Immune Responses (7 papers). Robert S. Yamamoto is often cited by papers focused on Immune Cell Function and Interaction (12 papers), Immune Response and Inflammation (10 papers) and Immunotherapy and Immune Responses (7 papers). Robert S. Yamamoto collaborates with scholars based in United States, Japan and Italy. Robert S. Yamamoto's co-authors include Gale A. Granger, John C. Hiserodt, Tetsuya Gatanaga, Carl F. Ware, Daryl S. Fair, Edward W. B. Jeffes, John E. Lewis, Gianna Scannell, Condie E. Carmack and Kenneth Waxman and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Robert S. Yamamoto

46 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert S. Yamamoto United States 16 441 267 107 104 63 46 756
Roberto Fagnani United States 10 389 0.9× 212 0.8× 97 0.9× 125 1.2× 23 0.4× 14 797
Minoru Sasano Japan 15 317 0.7× 234 0.9× 129 1.2× 187 1.8× 53 0.8× 48 918
Carla A. Martin United States 17 901 2.0× 340 1.3× 209 2.0× 117 1.1× 60 1.0× 29 1.4k
Eric A. Atkinson Canada 11 355 0.8× 510 1.9× 106 1.0× 45 0.4× 68 1.1× 14 915
Rigdon Lentz United States 5 610 1.4× 460 1.7× 155 1.4× 92 0.9× 155 2.5× 5 1.1k
Gretchen N. Schwartz United States 15 237 0.5× 210 0.8× 172 1.6× 91 0.9× 48 0.8× 33 616
Kathryn Pyne United States 12 470 1.1× 504 1.9× 146 1.4× 48 0.5× 121 1.9× 12 1.1k
Mariastefania Antica Croatia 16 516 1.2× 318 1.2× 162 1.5× 47 0.5× 103 1.6× 51 1.1k
Roberto González‐Amaro Mexico 14 339 0.8× 214 0.8× 109 1.0× 60 0.6× 36 0.6× 21 785
Shigeki Miyawaki Japan 17 660 1.5× 323 1.2× 106 1.0× 50 0.5× 160 2.5× 31 1.3k

Countries citing papers authored by Robert S. Yamamoto

Since Specialization
Citations

This map shows the geographic impact of Robert S. Yamamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Yamamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Yamamoto more than expected).

Fields of papers citing papers by Robert S. Yamamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Yamamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Yamamoto. The network helps show where Robert S. Yamamoto may publish in the future.

Co-authorship network of co-authors of Robert S. Yamamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Yamamoto. A scholar is included among the top collaborators of Robert S. Yamamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Yamamoto. Robert S. Yamamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamada, Kazunori, et al.. (2024). Adsorptive Removal of Bisphenol A by Polyethylene Meshes Grafted with an Amino Group-Containing Monomer, 2-(Dimethylamino)ethyl Methacrylate. SHILAP Revista de lepidopterología. 4(4). 431–446. 1 indexed citations
2.
Badgwell, Brian D., Daniel J. Valentino, Edward W. B. Jeffes, et al.. (2003). Intra-arterial administration of TNF-α followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma. Cancer Immunology Immunotherapy. 52(1). 10–16. 1 indexed citations
3.
Schreurs, Jolanda, Robert S. Yamamoto, S Munemitsu, et al.. (1995). Functional Wild‐Type and Carboxy‐Terminal‐Tagged Rat Substance P Receptors Expressed in Baculovirus‐Infected Insect Sf9 Cells. Journal of Neurochemistry. 64(4). 1622–1631. 15 indexed citations
4.
Lucci, Joseph A., Alberto Manetta, Federica Cappuccini, et al.. (1993). Immunotherapy of ovarian cancer. II. In vitro generation and characterization of lymphokine-activated killer T cells from the peripheral blood of recurrent ovarian cancer patients. International Journal of Gynecology & Obstetrics. 40(2). 179–180. 1 indexed citations
7.
Yamamoto, Robert S., Bharathi Vayuvegula, Sudhir Gupta, et al.. (1991). Generation of stimulated, lymphokine activated T killer (T-LAK) cells from the peripheral blood of normal donors and adult patients with recurrent glioblastoma. Journal of Immunological Methods. 137(2). 225–235. 12 indexed citations
8.
Jeffes, Edward W. B., et al.. (1991). A simple nonisotopic in vitro bioassay for LT and TNF employing sodium fluoride-treated L-929 target cells that detects picogram quantities of LT and TNF and is as sensitive as TNF assays done with ELISA methodology.. PubMed. 10(1-2). 147–51. 9 indexed citations
9.
10.
Yousefi, Shída, et al.. (1991). The paradoxical effects of somatostatin on the bioactivity and production of cytotoxins derived from human peripheral blood mononuclear cells. British Journal of Cancer. 64(2). 243–246. 12 indexed citations
11.
Jeffes, Edward W. B., et al.. (1991). Therapy of recurrent high-grade gliomas with surgery, autologous mitogen-activated IL-2-stimulated (MAK) killer lymphocytes, and rIL-2: II. Correlation of survival with MAK cell tumor necrosis factor production in vitro.. PubMed. 10(1-2). 89–94. 3 indexed citations
13.
Yamamoto, Robert S., et al.. (1990). The human lung fibroblast cell line, MRC-5, produces multiple factors involved with megakaryocytopoiesis.. The Journal of Immunology. 144(5). 1808–1816. 10 indexed citations
14.
Jeffes, Edward W. B., et al.. (1989). The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serum. Arthritis & Rheumatism. 32(9). 1148–1152. 15 indexed citations
15.
Song, Yilin, Kiyohito Naïto, Hiroyuki Yaguchi, et al.. (1989). [Lichen planus pemphigoides--report of a case and binding sites of circulating anti-basement membrane zone antibodies].. PubMed. 99(10). 1111–6. 2 indexed citations
16.
Kobayashi, Michiko, et al.. (1986). The human LT system. XII. Purification and functional studies of LT and "TNF-like" LT forms from a continuous human T cell line.. The Journal of Immunology. 137(6). 1885–1892. 35 indexed citations
19.
Hiserodt, John C., Robert S. Yamamoto, & Gale A. Granger. (1978). The human LT system. Cellular Immunology. 41(2). 380–396. 12 indexed citations
20.
Lewis, John E., Condie E. Carmack, Robert S. Yamamoto, & Gale A. Granger. (1977). Antibodies against human lymphokines: I. Methods for induction of antibodies capable of neutralizing stable (α) and unstable (β) lymphotoxins released in vitro by activated human lymphocytes. Journal of Immunological Methods. 14(2). 163–176. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026